Our data show that higher expression of MSR1 in the lung was associated with worse clinical prognoses in IPF patients after lung transplantation, suggesting that MSR1 might serve as one potential quantitative tool to gauge posttransplant survival. This evidence concerns the gene MSR1 and idiopathic pulmonary fibrosis.